These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8959623)

  • 1. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
    Drukker A; Eddy AA
    J Am Soc Nephrol; 1998 Feb; 9(2):243-51. PubMed ID: 9527400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin in chronic puromycin aminonucleoside nephrosis.
    Magil AB; Pichler RH; Johnson RJ
    J Am Soc Nephrol; 1997 Sep; 8(9):1383-90. PubMed ID: 9294829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T; Morohoshi T
    Nephron; 1992; 60(4):443-7. PubMed ID: 1584321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
    Pedraza-Chaverri J; Arévalo AE; Hernández-Pando R; Larriva-Sahd J
    Int J Biochem Cell Biol; 1995 Jul; 27(7):683-91. PubMed ID: 7648424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T; Mamo JC; Nagano S; Sugisaki T
    Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
    Diamond JR; Anderson S
    Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS; Renaud L; Drummond KN
    Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
    Diamond JR; Hanchak NA; McCarter MD; Karnovsky MJ
    Am J Clin Nutr; 1990 Apr; 51(4):606-11. PubMed ID: 2321567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome.
    Diamond JR; Ding G; Frye J; Diamond IP
    Am J Pathol; 1992 Oct; 141(4):887-94. PubMed ID: 1415482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR; Pesek I
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.